Alle verbonden artikelen

Immune-Related Antigens, Surface Molecules and Regulatory Factors in Human-Derived Mesenchymal Stromal Cells: The Expression and Impact of Inflammatory Priming.

Auteurs : Najar M, Raicevic G, Kazan HF, De Bruyn C, Bron D, Toungouz M, Lagneaux L
Jaar : 2012
Journal : Stem Cell Rev
Volume : 8(4)
Pagina's : 1188-98

Role and interpretation of FDG-PET/CT in HIV patients with fever of unknown origin: a prospective study.

Auteurs : Martin C, Castaigne C, Tondeur M, Flamen P, De Wit S
Jaar : 2012
Journal : J Int AIDS Soc
Volume : 15(4)
Pagina's : 18107

Decision-making in oncology: a selected literature review and some recommendations for the future.

Auteurs : Ménard C, Merckaert I, Razavi D, Libert Y
Jaar : 2012
Journal : Curr Opin Oncol
Volume : 24(4)
Pagina's : 381-90

Assessment of the intrinsic pluripotency of mesoderm-derived stem cells from different niches.

Auteurs : De Kock J, Najar M, Bolleyn J, Al Battah F, Raicevic G, Govaere O, Branson S, Meganathan K, Gaspar JA, Roskams T, Sachinidis A, Lagneaux L, Vanhaecke T, Rogiers V
Jaar : 2012
Journal : ALTEX
Volume : 29
Pagina's : 31-9

Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): A phase II randomised study by the European Lung Cancer Wo

Auteurs : Berghmans T, Lafitte JJ, Giner V, Berchier MC, Scherpereel A, Lewin D, Paesmans M, Meert AP, Bosschaerts T, Leclercq N, Sculier JP
Jaar : 2012
Journal : Lung Cancer
Volume : 77(3)
Pagina's : 605-610

Clinical trial design in head and neck cancer: from past experiences to future perspectives.

Auteurs : de Castro G Jr, Henrique dos Anjos C, Lalami Y, Awada A
Jaar : 2012
Journal : Clinical Investigation
Volume : 2(5)
Pagina's : 473-481

A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints.

Auteurs : Fumagalli D, Bedard PL, Nahleh Z, Michiels S, Sotiriou C, Loi S, Sparano JA, Ellis M, Hylton N, Zujewski JA, Hudis C, Esserman L, Piccart-Gebhart M
Jaar : 2012
Journal : Lancet Oncol
Volume : 13(6)
Pagina's : e240-8

Euthanasia: from ethical debate to clinical reality.

Auteurs : Berghmans T, Lossignol D
Jaar : 2012
Journal : Eur. Respir. J.
Volume : 40(4)
Pagina's : 804-5

Communication skills training for residents : which variables predict learning of skills?

Auteurs : Bragard I, Merckaert I, Libert Y, Delvaux N, Etienne AM, Marchal S, Reynaert C, Razavi D
Jaar : 2012
Journal : Open Journal of Medical Psychology
Volume : 1
Pagina's : 68-75

Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement.

Auteurs : Guiu S, Michiels S, André F, Cortes J, Denkert C, Di Leo A, Hennessy BT, Sorlie T, Sotiriou C, Turner N, van de Vijver M, Viale G, Loi S, Reis-Filho JS
Jaar : 2012
Journal : Ann Oncol
Volume : 23
Pagina's : 2997-3006

Liquid biopsy to test new treatment strategies in breast cancer: are we there yet?

Auteurs : Ignatiadis M, Piccart-Gebhart M
Jaar : 2012
Journal : Ann Oncol
Volume : 23(7)
Pagina's : 1653-5

Technological innovation and healthcare professionals' workloads: an ambiguous relationship.

Auteurs : de Pires DE, Bertoncini JH, Trindade Lde L, Matos E, de Azambuja E, Borges AM
Jaar : 2012
Journal : Rev Gaucha Enferm
Volume : 33(1)
Pagina's : 157-68

Anaplastic lymphoma kinase (ALK) inhibitors for second-line therapy of non-small cell lung cancer.

Auteurs : Berghmans T, Remmelink M, Awada A
Jaar : 2012
Journal : Lung Cancer : Targets and Therapy
Volume : 3
Pagina's : 91-99

New strategies and designs in pancreatic cancer research: consensus guidelines report from a European expert panel.

Auteurs : Van Laethem JL, Verslype C, Iovanna JL, Michl P, Conroy T, Louvet C, Hammel P, Mitry E, Ducreux M, Maraculla T, Uhl W, Van Tienhoven G, Bachet JB, Maréchal R, Hendlisz A, Bali M, Demetter P, Ulrich F, Aust D, Luttges J, Peeters M, Mauer M, Roth A, Neoptolemos JP, Lutz M
Jaar : 2012
Journal : Ann Oncol
Volume : 23
Pagina's : 570-576

Triple negative breast cancer: proposals for a pragmatic definition and implications for patient management and trial design.

Auteurs : Eiermann W, Bergh J, Cardoso F, Conte P, Crown J, Curtin NJ, Gligorov J, Gusterson B, Joensuu H, Linderholm BK, Martin M, Penault-Llorca F, Pestalozzi BC, Razis E, Sotiriou C, Tjulandin S, Viale G
Jaar : 2012
Journal : Breast
Volume : 21(1)
Pagina's : 20-6

Pemetrexed salvage chemotherapy for NSCLC: implementation study].

Auteurs : Jungels C, Berghmans T, Meert AP, Lafitte JJ, Scherpereel A, Sculier JP
Jaar : 2012
Journal : Rev Mal Respir
Volume : 29(1)
Pagina's : 21-7

A phase II randomized study of combined infusional leucovorin sodium and 5- FU versus the leucovorin calcium followed by 5-FU both in combination with irinotecan or oxaliplatin in patients with metastatic colorectal cancer.

Auteurs : Bleiberg H, Vandebroek A, Deleu I, Vergauwe P, Rezaei Kalantari H, DHaens G, Paesmans M, Peeters M, Efira A, Humblet Y
Jaar : 2012
Journal : Acta Gastroenterol Belg
Volume : 75(1)
Pagina's : 14-21

Phase I trial to investigate the safety, pharmacokinetics and efficacy of sorafenib combined with docetaxel in patients with advanced refractory solid tumours.

Auteurs : Awada A, Hendlisz A, Christensen O, Lathia CD, Bartholomeus S, Lebrun F, de Valeriola D, Brendel E, Radtke M, Delaunoit T, Piccart-Gebhart M, Gil T
Jaar : 2012
Journal : Eur. J. Cancer
Volume : 48(4)
Pagina's : 465-74

Systemic treatment of brain metastases in HER2-positive breast cancer: current status and future directions.

Auteurs : Azim H, Azim HA
Jaar : 2012
Journal : Future Oncol
Volume : 8(2)
Pagina's : 135-44

Clinical development of insulin-like growth factor receptor-1 (IGF-1R) inhibitors: At the crossroad?

Auteurs : Gombos A, Metzger-Filho O, Dal Lago L, Awada A
Jaar : 2012
Journal : Invest New Drugs
Volume : 30(6)
Pagina's : 2433-42